Skip to Main Content
Table 3—

Logistic regression results in subjects with no retinopathy at baseline

ParameterOR (95% CI)P value
Randomization group (control vs. intervention) 5.35 (1.14–25.12) 0.034 
A1C 1.76 (1.07–2.90) 0.025 
Age (years) 1.15 (1.05–1.25) 0.002 
Female sex 1.19 (0.48–2.95) 0.704 
Diabetes duration (years) 1.02 (0.94–1.10) 0.677 
Follow-up (months) 0.94 (0.85–1.05) 0.287 
Race   
    Non-Hispanic white — — 
    Hispanic 1.07 (0.34–3.40) — 
    Black 1.65 (0.33–8.11) — 
    Other 1.18 (0.17–8.39) 0.739 
ParameterOR (95% CI)P value
Randomization group (control vs. intervention) 5.35 (1.14–25.12) 0.034 
A1C 1.76 (1.07–2.90) 0.025 
Age (years) 1.15 (1.05–1.25) 0.002 
Female sex 1.19 (0.48–2.95) 0.704 
Diabetes duration (years) 1.02 (0.94–1.10) 0.677 
Follow-up (months) 0.94 (0.85–1.05) 0.287 
Race   
    Non-Hispanic white — — 
    Hispanic 1.07 (0.34–3.40) — 
    Black 1.65 (0.33–8.11) — 
    Other 1.18 (0.17–8.39) 0.739 

Dependent variable = development of retinopathy (n = 82).

Close Modal

or Create an Account

Close Modal
Close Modal